Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

A Simple and Rapid Light-Initiated Chemiluminescence Assay for Quantitation of Artemisia-Specific Immunoglobulin E.

Authors:
Dandan Liu Bei Zhang Lina Zhu Lisheng Zheng Shaoshen Li Xin Tan Yang Yu Huiqiang Li

Int Arch Allergy Immunol 2022 16;183(5):490-497. Epub 2021 Dec 16.

Department of Clinical Immunology, School of Medical Laboratory, Tianjin Medical University, Tianjin, China.

Background: Light-initiated chemiluminescence assay (LICA) is a homogeneous assay that has been successfully used for the quantitation of food allergen-specific immunoglobulin E (sIgE), but not inhaled allergen-sIgE. Simultaneously, current assays used to detect allergen-sIgE are serum consuming and/or time consuming. Hence, we established a method for the quantitation of Artemisia-sIgE based on LICA and verified its performance according to the clinical guideline documents, laying a foundation for the quantitation of inhaled and food allergen-sIgE in parallel on LICA.

Methods: The assay was established after optimizing the first incubation time and the dilutions of Artemisia-coated chemibeads, biotinylated goat anti-human IgE, and serum. In order to quantitate Artemisia-sIgE, the calibration curve was established with a high positive serum of known concentration. The assay performance was confirmed per the clinical guideline documents. In addition, the correlation between the results of LICA and capture enzyme-linked immunosorbent assay was evaluated.

Results: The developed LICA's coefficients of variation of repeatability and intermediate precision were 3.20%, 2.14%, and 3.85% and 4.30%, 4.00%, and 4.40%, respectively. The limit of detection was 0.10 kUA/L, and the limit of quantitation was 0.11 kUA/L. The range of linearity was from 0.27 kUA/L to 97.53 kUA/L (r = 0.9968). The correlation coefficient (r) for the correlation analysis between results of LICA and capture ELISA was 0.9087. This assay was successfully applied in 64 human serum samples, showing good sensitivity (82.20%) and specificity (100%).

Conclusion: An Artemisia-sIgE quantitation assay based on LICA was successfully established. Its performance satisfied the clinical requirements and could be widely used in clinical laboratories.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000520511DOI Listing
May 2022

Publication Analysis

Top Keywords

lica capture
8
guideline documents
8
clinical guideline
8
light-initiated chemiluminescence
8
assay
8
chemiluminescence assay
8
assay quantitation
8
based lica
8
quantitation
6
lica
5
developed lica's
4
clinical laboratories
4
evaluatedresults developed
4
assay evaluatedresults
4
immunosorbent assay
4
enzyme-linked immunosorbent
4
lica's coefficients
4
repeatability intermediate
4
coefficients variation
4
variation repeatability
4

Keyword Occurance

Similar Publications

A Simple and Rapid Light-Initiated Chemiluminescence Assay for Quantitation of Artemisia-Specific Immunoglobulin E.

Authors:
Dandan Liu Bei Zhang Lina Zhu Lisheng Zheng Shaoshen Li Xin Tan Yang Yu Huiqiang Li

Int Arch Allergy Immunol 2022 16;183(5):490-497. Epub 2021 Dec 16.

Department of Clinical Immunology, School of Medical Laboratory, Tianjin Medical University, Tianjin, China.

Background: Light-initiated chemiluminescence assay (LICA) is a homogeneous assay that has been successfully used for the quantitation of food allergen-specific immunoglobulin E (sIgE), but not inhaled allergen-sIgE. Simultaneously, current assays used to detect allergen-sIgE are serum consuming and/or time consuming. Hence, we established a method for the quantitation of Artemisia-sIgE based on LICA and verified its performance according to the clinical guideline documents, laying a foundation for the quantitation of inhaled and food allergen-sIgE in parallel on LICA. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Competition between Allowed and First-Forbidden β Decay: The Case of ^{208}Hg→^{208}Tl.

Authors:
R J Carroll Zs Podolyák T Berry H Grawe T Alexander A N Andreyev S Ansari M J G Borge M Brunet J R Creswell L M Fraile C Fahlander H O U Fynbo E R Gamba W Gelletly R-B Gerst M Górska A Gredley P T Greenlees L J Harkness-Brennan M Huyse S M Judge D S Judson J Konki J Kurcewicz I Kuti S Lalkovski I H Lazarus R Lică M Lund

Phys Rev Lett 2020 Nov;125(19):192501

Department of Physics and Astronomy, Aarhus University, DK-8000 Aarhus, Denmark.

The β decay of ^{208}Hg into the one-proton hole, one neutron-particle _{81}^{208}Tl_{127} nucleus was investigated at CERN-ISOLDE. Shell-model calculations describe well the level scheme deduced, validating the proton-neutron interactions used, with implications for the whole of the N>126, Z<82 quadrant of neutron-rich nuclei. While both negative and positive parity states with spin 0 and 1 are expected within the Q_{β} window, only three negative parity states are populated directly in the β decay. Read More

View Article and Full-Text PDF
November 2020
Similar Publications

Setting Our Sights on Infectious Diseases.

Authors:
Manu De Rycker David Horn Bree Aldridge Richard K Amewu Clifton E Barry Frederick S Buckner Sarah Cook Michael A J Ferguson Nathalie Gobeau Jennifer Herrmann Paul Herrling William Hope Jennifer Keiser Maria Jose Lafuente-Monasterio Paul D Leeson Didier Leroy Ujjini H Manjunatha James McCarthy Timothy J Miles Valerie Mizrahi Olena Moshynets Jacquin Niles John P Overington John Pottage Srinivasa P S Rao Kevin D Read Isabela Ribeiro Lynn L Silver Jen Southern Thomas Spangenberg

ACS Infect Dis 2020 01 6;6(1):3-13. Epub 2019 Dec 6.

Global Health Institute of Merck, Ares Trading S.A. , a subsidiary of Merck KGaA Darmstadt Germany , Route de Crassier 1 , 1262 Eysins , Switzerland.

In May 2019, the Wellcome Centre for Anti-Infectives Research (CAIR) at the University of Dundee, UK, held an international conference with the aim of discussing some key questions around discovering new medicines for infectious diseases and a particular focus on diseases affecting Low and Middle Income Countries. There is an urgent need for new drugs to treat most infectious diseases. We were keen to see if there were lessons that we could learn across different disease areas and between the preclinical and clinical phases with the aim of exploring how we can improve and speed up the drug discovery, translational, and clinical development processes. Read More

View Article and Full-Text PDF
January 2020
Similar Publications

Development and preliminary evaluation of a novel low cost VR-based upper limb stroke rehabilitation platform using Wii technology.

Authors:
Emmanuel Tsekleves Ioannis Theoklitos Paraskevopoulos Alyson Warland Cherry Kilbride

Disabil Rehabil Assist Technol 2016 13;11(5):413-22. Epub 2014 Nov 13.

c School of Health Sciences & Social Care , Brunel University , London , UK.

Purpose: This paper proposes a novel system (using the Nintendo Wii remote) that offers customised, non-immersive, virtual reality-based, upper-limb stroke rehabilitation and reports on promising preliminary findings with stroke survivors.

Method: The system novelty lies in the high accuracy of the full kinematic tracking of the upper limb movement in real-time, offering strong personal connection between the stroke survivor and a virtual character when executing therapist prescribed adjustable exercises/games. It allows the therapist to monitor patient performance and to individually calibrate the system in terms of range of movement, speed and duration. Read More

View Article and Full-Text PDF
January 2017
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap